Point72 (DIFC)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,400
Closed -$1.01M 1822
2025
Q1
$1.01M Buy
2,400
+1,400
+140% +$608K 0.04% 460
2024
Q4
$413K Buy
1,000
+100
+11% +$43.9K 0.02% 695
2024
Q3
$455K Sell
900
-600
-40% -$291K 0.02% 679
2024
Q2
$731K Sell
1,500
-1,400
-48% -$703K 0.03% 588
2024
Q1
$1.57M Buy
+2,900
New +$1.58M 0.05% 453

Other funds holding IDXX

Point72 (DIFC)'s IDXX Position: Q2 2024 in Review

Point72 (DIFC) sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 7,275 shares — an estimated $3.65M sold.

Point72 (DIFC) first reported a position in IDXX in Q1 2024 and held it in 1 quarter. The position peaked at $3.93M in Q1 2024. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Point72 (DIFC) reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Point72 (DIFC) sold 7,275 Idexx Laboratories shares in Q2 2024, an estimated $3.65M.
  • Point72 (DIFC) first reported a position in Idexx Laboratories in Q1 2024 and held it in 1 quarter.
  • Point72 (DIFC)'s Idexx Laboratories position peaked at $3.93M in Q1 2024.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Point72 (DIFC)'s 13F filing for Q2 2024, filed 14 Aug 2024.